Myomo, Inc.

US$1.21As of Sun 8 Nov 2026, 12:00 UTC
AMEX:MYOHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (45.00%)
Div yield —
ROE (123.76%)
Medical Devices
Beta (5Y) 1.71
PE TTM —
TSR TTM 30.67%
Mkt cap US$47.93M
ROIC (26.14%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.55
28.42%
188.88%
Sell 4|0|11|1|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
17.61%
13.65%
16.22%
13.33%
Revenue$M
2.526
2.519
2.500
2.608
14.23%
12.98%
7.18%
7.25%
Peers (US$47.93M)
Cap (US$)
PE
47.96M
—
47.51M
—
Capital
TTM
5Y
10Y
Leveragex
5.304
0.880
0.831
EBIT/Intx
0.425
0.444
0.361
Own earn%
99.45
(87.12)
(97.43)
Sh yield%
35.94
33.57
34.35
Owners
Insiders/Inst%
7.09
23.96
Short interest%
3.92
SBC / revenue%
0.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
0–6
$1 testx
0.0
Incr. ROIC%
2